Status:
COMPLETED
Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder
Lead Sponsor:
Utrecht Institute for Pharmaceutical Sciences
Conditions:
ADHD
Eligibility:
All Genders
21-55 years
Phase:
PHASE4
Brief Summary
The primary purpose of this study is to determine the effects of methylphenidate versus placebo on driving ability of adult ADHD patients.
Detailed Description
This study was set-up to examine the controversial issue whether or not it is safe to drive a car or not when treated with methylphenidate. On-the-road driving tests during normal traffic are conduct...
Eligibility Criteria
Inclusion
- adult ADHD patient over 21 years old
- valid driver's license for at least 3 years
- treated with methylphenidate
- written informed consent
Exclusion
- use of illicit drugs
- use of drugs or having medical conditions known to affect driving ability
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
End Date :
February 1 2006
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00223561
Start Date
February 1 2003
End Date
February 1 2006
Last Update
March 1 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Utrecht Institute for Pharmaceutical Sciences
Utrecht, Netherlands, 3508 TB